Published in Stem Cells Transl Med on June 22, 2016
Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality. Stem Cell Res Ther (2017) 0.75
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics (1998) 49.00
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells (2007) 8.64
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Immunomodulatory properties of mesenchymal stromal cells. Blood (2007) 6.97
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature (2014) 6.94
Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells (2007) 3.79
Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol (2010) 3.70
Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells (2005) 3.03
Gene therapy clinical trials worldwide to 2007--an update. J Gene Med (2007) 2.56
Venezuelan equine encephalitis. Annu Rev Entomol (2004) 2.50
mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci Transl Med (2013) 2.10
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci (2005) 2.07
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis (1997) 1.75
Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine (1996) 1.74
Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells. J Clin Microbiol (1976) 1.45
Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev (2008) 1.42
Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther (2008) 1.40
Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg (2004) 1.39
Biological weapons--a primer for microbiologists. Annu Rev Microbiol (2001) 1.38
Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Vaccine (2005) 1.27
REVIEW PAPER: pathology of animal models of alphavirus encephalitis. Vet Pathol (2010) 1.26
Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther (2010) 1.19
Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp Hematol (2000) 1.18
In vitro immunologic properties of human umbilical cord perivascular cells. Cytotherapy (2008) 1.15
Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther (2003) 1.13
Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Vaccine (2003) 1.10
High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol (2009) 1.10
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther (2001) 1.09
Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds. Stem Cells (2009) 1.09
Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. PLoS One (2010) 1.08
Central nervous system demyelination in Venezuelan equine encephalomyelitis infection. J Neurol Sci (1981) 1.04
Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates. Vaccine (2008) 1.01
Concise review: immunomodulatory properties of mesenchymal stem cells in cellular transplantation: update, controversies, and unknowns. Stem Cells Transl Med (2012) 0.94
Venezuelan equine encephalitis virus activity in the Gulf Coast region of Mexico, 2003-2010. PLoS Negl Trop Dis (2012) 0.94
Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs. J Virol (2013) 0.94
Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin Microbiol Rev (2015) 0.92
Therapeutic cell carriers: a potential road to cure glioma. Expert Rev Neurother (2014) 0.91
Concise review: stem cells as an emerging platform for antibody therapy of cancer. Stem Cells (2010) 0.91
Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV. Cancer Gene Ther (2008) 0.90
Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta (2010) 0.90
Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface. J Tissue Eng Regen Med (2010) 0.90
Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma. Mol Pharm (2012) 0.88
Isolation, characterization, and differentiation of human umbilical cord perivascular cells (HUCPVCs). Methods Cell Biol (2008) 0.86
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases. Int J Mol Sci (2014) 0.84
Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. PLoS One (2012) 0.83
A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus. Vaccine (2010) 0.82
Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models. Stem Cells Transl Med (2013) 0.81
Antibody gene-based prophylaxis and therapy for biodefence. Hum Vaccin (2007) 0.81
In vivo bioluminescence imaging of magnetically targeted bone marrow-derived mesenchymal stem cells in skeletal muscle injury model. J Orthop Res (2012) 0.80
Human mesenchymal stem cells overexpressing therapeutic genes: from basic science to clinical applications for articular cartilage repair. Biomed Mater Eng (2012) 0.80
Humanization and mammalian expression of a murine monoclonal antibody against Venezuelan equine encephalitis virus. Vaccine (2007) 0.78
Endogenous anti-tumor antibody responses in nude mice. Cancer (1997) 0.77
The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases. PLoS Pathog (2015) 0.77